AstraZeneca up after diabetes combo passes phase III
The trial met the met the primary endpoint of a better performance that the single medicines alone said the pharma
Company
Merck & Co Inc
NYSE:MRK
Merck & Co Inc is a global healthcare company. The company offers health solutions through its prescription medicines, including biological therapies, vaccines and animal health products.
138 stories · page 7 of 7
Merck/Pfizer ready new diabetes drug after trial success
Ertugliflozin is an investigational oral treatment for type 2 diabetes
Merck axes osteoporosis treatment odanacatib
Some benefit for bones but stroke risk too great said Merck
Medivation faces buyers’ scrum - report
A scrum to acquire US cancer drug company Medivation was emerging on Wednesday after reports that Merck, Pfizer and Gilead Sciences were among at least five pharmaceutical companies expressing an interest
Healthy oil rise keeps markets afloat, helps energy stocks
Investors cautious on Monday following a burst of optimism
US markets ease back from record levels
A strong non-farm payrolls number eased some concerns in the market over the health of the US economy.
Bristol Myers slumps as immunotherapy drug fails lung cancer trial
The news immediately boosted shares in Merck (NYSE:MRK), which has a rival immunotherapy treatment, Keytruda.
Jefferies keeps Merck medicine on the shelf
Broker coverage: Merck & Co, Pozen, AuRico Minerals
Investments and investor services
Proactive news highlights: Horse Hill, Cairn Energy, Redx Pharma, React Energy and more
Green Dragon, Midatech Pharma and BATM Advanced Communications also had news out on Monday
Redx Pharma adds former Merck R&D specialist to its board
Dr Bernhard Kirschbaum, 57, has been added as a non-executive director with immediate effect.
Investments and investor services
Trending: Live Ventures soars ahead of ‘special’ Q4 report
Live Ventures has raised expectations ahead of what it said would be a special quarterly report next Thursday, meanwhile, drug developer Relypsa shares rose 16% on takeover speculation.
Pfizer agrees US$150bn Allergan merger
The combined group will become the world’s largest drug company.
NewLink Genetics and Merck vaccine shown to be 100% effective against Ebola
The VSV-EBOV vaccine was first developed by Canada’s Public Health Agency and licensed by NewLink, which then signed an exclusive licensing agreement with Merck to develop the vaccine candidate.
Wall Street breaks 5-day losing run as investors look for tomorrow’s Fed statement
U.S. stocks halted the five-day losing streak today, as investors looked past softer economic reports and a continued rout in China’s stock market, and waited for the outcome of the two-day Federal Reserve. The S&P 500 (INDEXSP:.I
Cancer drug firms to cash in on $9bn immunotherapy market
Trials have shown that immunotherapy may revolutionise cancer treatment